Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- Biosimilars Poised to Move Needle in GI, but Hurdles Remain
-
- 8 Recent Reports on Treatment, New Trials from International NASH Day
- CD40 May be Key to Activating Immune Response in Pancreatic Cancer
- Combination HBV Therapy Shows Functional Control 24 Weeks After Cessation
- Crohn’s & Colitis Foundation Funding Microbiome IBD Drug Development
- The Cost of Biosimilars, Lessons from Hepatitis C Leonard H. Calabrese, DO
- Acid Suppressors Reduce Risk for Esophageal Adenocarcinoma in BE
- Dose Intensification Helps Restore Response to Entyvio
- Gastric Cancer Screening Cost-effective in Some US Populations
-
- Most GIs Believe IBS Diets ‘As Good or Better’ Than Medical Therapy
- Pregnant Mothers’ Diet may Impact Baby’s Gut Microbiome
- Telehealth VA Program Aids in Identification of Liver Transplant Candidates
- Ultra-processed Foods Linked to IBS
- VIDEO: Artificial Intelligence Enterprise Gains Partner in Colon Cancer Screening Development
- Certain Bariatric Procedures Linked to Higher Risk for GERD, Esophagitis
- VIDEO: DDW 2018 Review: Obesity Treatment Integral to Gastroenterology Care
- IL-13 Inhibitor Effective, Safe for Long-term Treatment of EoE
-
- Ready-to-drink Solution Superior to Powder for Colonoscopy Bowel Prep
- Stressful Events in Adulthood Linked to Increased Risk for IBS
- ASGE Names New President
- Commentary: Further Benefits to Consider for Noninvasive Colon Cancer Screening
- MD Anderson’s CRC Moon Shot Team Designed to Fundamentally Change Detection, Treatment
- Nurse Practitioners Well-positioned to Improve Colon Cancer Screening Rates